QuantiFERON® SARS-CoV-2 for COVID-19 T-cell response
Valuable insights into our immune system’s response to COVID-19
To control the pandemic, we must first understand and control the infection
T-cell response has the potential to give a clearer picture of immunity and course of illness.
Learn how QuantiFERON® SARS-CoV-2 can help you explore immune response markers in SARS-CoV-2 infections and better understand their role in COVID-19.
QuantiFERON® SARS-CoV-2 solution detects T-cell responses of the human immune system to the pathogen that causes COVID-19, to determine immunity levels and disease progression.
QIAGEN launches CE-marked version of QuantiFERON® SARS-CoV-2 to assess T-cell response to COVID-19
Recognize T-cell response in COVID-19 infections
Unlock immune response potential for better insights
Based on world leading QFT IGRA technology
For your information
About QuantiFERON® SARS-CoV-2
Studies suggest that T-cell response to SARS-CoV-2 declines much more slowly than antibody response, which presents several benefits to researchers who want to push beyond the existing detection of active infections to screen for potential courses of the illness and long-term immune responses to it.
Studies show growing evidence that T-cell response gives a reliable indication of how severe the course of an illness triggered by SARS-CoV-2 will be in infected patients, and how immune those who have recovered remain months – possibly even years – after having been infected.
QuantiFERON® SARS-CoV-2 is a flexible, modular system designed to meet a wide range of research demands. It is based on QIAGEN’s easy-to-use QuantiFERON® technology, pioneered in the QuantiFERON® -TB Gold Plus test for latent tuberculosis and recognized worldwide for its ability to detect interferon gamma that T-cells release upon contact with certain pathogens.
- T-cell response to SARS-CoV-2 may decline less rapidly than antibodies
- T-cell response has the potential to give a clearer picture of immunity and course of illness
Get in contact with the QuantiFERON® SARS-CoV-2 responsible.
Fill out the form, and we will reach out shortly.
Other interesting content
Looking for something else? You might be interested in this as well.
QFT CMV – Monitor transplant patient’s level of anti-CMV immunity
QuantiFERON® – CMV is a blood test that measures the immune response of CD8+ cells to CMV. The test is used to monitor people’s risks of developing CMV disease and can be used in connection with organ transplants to predict whether patients have an increased risk of developing CMV disease.
QFT TB-Gold Plus – Detect TB with confidence
QuantiFERON® TB-Gold Plus is an ELISA test for the detection of M. tuberculosis in immunocompetent individuals. The analysis is particularly relevant in those who have received the BCG vaccine, as the analysis, in contrast to skin tests with tuberculin (Mantoux), can distinguish between infection with M. tuberculosis and vaccination.
Please, reach out if you have questions, comments or requests.